Target intelligence / Profile preview

Cardiac action potential propagation

Molecular classification
Other
01

Overview

Cardiac action potential propagation refers to the physiological process by which electrical impulses, generated by ion fluxes across the cardiac cell membrane, are transmitted from one cardiac myocyte to another throughout heart tissue. This propagation is crucial for coordinated contraction of the heart and is determined by complex interactions among ion channels, gap junctions, the tissue structure of the heart, and the local microenvironment. While propagating action potentials are essential for normal cardiac function, abnormalities in this process can contribute to arrhythmias and other heart diseases. This entity is not a discrete molecule, protein, or receptor, but rather an integrative physiological phenomenon arising from multiple molecular mechanisms, especially the coordinated action of various ion channels (e.g., sodium, potassium, calcium channels), cell-cell junctional communication (gap junctions), and tissue-level properties[1][3][8][10]. Detailed evaluation: - "Cardiac action potential propagation" is not a molecule, protein, enzyme, transporter, or receptor, but a physiological process describing the electrical conduction through cardiac tissue[1][3][4][10]. - No unique canonical name, abbreviation, or specific molecular classification fits (e.g., unlike "Sodium channel protein type 1 subunit alpha" or "Connexin 43"). - The primary molecular underpinnings involve clusters of cardiac ion channels (Na⁺, K⁺, Ca²⁺), gap junctions (primarily connexins), and supporting cellular architecture, but none individually embody "cardiac action potential propagation"[1][3][7][8]. - As such, it cannot be considered a conventional drug target. Instead, multiple molecules and pathways involved in this process may be drug targets (e.g., sodium channels for antiarrhythmics), but not the propagation process itself. - If structured or drug-target-centric information is required, focus should shift to individual ion channels (SCN5A, KCNQ1), connexin proteins (such as Connexin 43), or defined components of the cardiac conduction system.

Other names
Cardiac impulse propagationCardiac action potential transmissionCardiac signal conduction
02

Biological functions

Electrical impulse conductionCardiac muscle excitationHeart rhythm regulation
03

Disease associations

Cardiovascular diseaseArrhythmia

Beyond the preview

Go deeper on Cardiac action potential propagation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac action potential propagation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call